← All trials
NCT05573425
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 22, 2020
- Primary completion
- Feb 21, 2021
- Completion date
- Feb 21, 2021
- First posted
- Oct 10, 2022
- Last posted
- Oct 13, 2022
- Enrollment
- 202
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Jinnah Postgraduate Medical CentreLead sponsor
- Jinnah Postgraduate Medical CentreReponsible party - principal investigator
- Jinnah Postgraduate Medical CentreStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.